Terry E. O’Reilly
Impact in
-
- Bone health and treatments
-
- Bone and Joint Diseases
Papers in
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Heidi A. Lane (2 shared papers)Reto Cortesi (1 shared paper)Mira Šuša (1 shared paper)Sabine Zumstein-Mecker (1 shared paper)Michaela Kneissel (1 shared paper)Σοφία Κοσσίδα (1 shared paper)Paul M.J. McSheehy (2 shared papers)Markus Wartmann (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)European Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)Expert Opinion on Biological Therapy (1 paper)
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
Terry E. O’Reilly
30 papers receiving 499 citations
Peers
Comparison fields: 5 of 83
- Oncology 144
- Orthopedics and Sports Medicine 31
- Nephrology 25
- Hepatology 26
- Genetics 33
Countries citing papers authored by Terry E. O’Reilly
This map shows the geographic impact of Terry E. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry E. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry E. O’Reilly more than expected).
Fields of papers citing papers by Terry E. O’Reilly
This network shows the impact of papers produced by Terry E. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry E. O’Reilly. The network helps show where Terry E. O’Reilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Terry E. O’Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 136 | |
| 2 | 2015 | 68 | |
| 3 | 2010 | 62 | |
| 4 | 2020 | 49 | |
| 5 | 2019 | 45 | |
| 6 | 2004 | 27 | |
| 7 | 2019 | 23 | |
| 8 | 2022 | 20 | |
| 9 | 2014 | 13 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2017 | 7 | |
| 13 | 2019 | 5 | |
| 14 | 1987 | 5 | |
| 15 | 1996 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 1998 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2020 | 3 |
About Terry E. O’Reilly
Terry E. O’Reilly is a scholar working on Epidemiology, Hepatology, Genetics, Oncology and Molecular Biology, having authored 32 papers that have together received 522 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Hormonal Regulation and Hypertension (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Estrogen and related hormone effects (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Oncology (144 citations), Orthopedics and Sports Medicine (31 citations), Nephrology (25 citations), Hepatology (26 citations) and Genetics (33 citations). Terry E. O’Reilly has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Heidi A. Lane, Reto Cortesi, Mira Šuša, Sabine Zumstein-Mecker, Michaela Kneissel, Σοφία Κοσσίδα, Paul M.J. McSheehy, Markus Wartmann, Steven A. Lacy and Peter Lassota. Their work appears in journals such as The Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Alimentary Pharmacology & Therapeutics and Expert Opinion on Biological Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.